Prospective observational study on pain relief, functional evaluation and safety of human adipose-derived mesenchymal stem cell culture supernatant solution for acute and chronic pain Singl-center, single-arm open study
Not Applicable
- Conditions
- Acute pain and Chronic pain
- Registration Number
- JPRN-UMIN000049726
- Lead Sponsor
- General incorporated association Advalife Science SINCLAIR GINZA CLINIC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have taken anti-inflammatory analgesics within 8 hours prior to the administration of the study drug 2. Patients who have used sleeping pills, psychotropic drugs, or other psychiatric drugs within 24 hours prior to administration of the study drug 3. Patients suffering from infectious diseases 4. Patients with a history of cancer or active malignancy 5. Patients with hypoglycemic symptoms prior to administration of the study drug 6. Patients who are judged to be inappropriate as research subjects by the principal investigator and principal study investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method